News
LEO Pharma receives positive CHMP opinion of Adtralza
LEO Pharma has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending to extend the approval of Adtralza in the European Union (EU).